Pharmosa Biopharm Inc. (TPEX:6875)

Pharmosa Biopharm Revenue

Pharmosa Biopharm had revenue of 15.68M TWD in the quarter ending June 30, 2025, with 64.31% growth. This brings the company's revenue in the last twelve months to 173.63M, down -46.43% year-over-year. In the year 2024, Pharmosa Biopharm had annual revenue of 167.57M, down -46.72%.

• Revenue (ttm): 173.63M
• Revenue Growth: -46.43%
• P/S Ratio: 28.55
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	167.57M	-146.93M	-46.72%
Dec 31, 2023	314.50M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-